Technology | November 26, 2012

Siemens Presents New Angiography Systems at RSNA 2012

Systems introduce new X-ray tube, detector technology and visualization software

Siemens Artis Q Artis Q.zen Angiography Systems

November 26, 2012 — At the 98th annual meeting of the Radiological Society of North America (RSNA) in Chicago, Siemens Healthcare is displaying for the first time its new X-ray tube and detector technology for the Artis Q and Artis Q.zen angiography systems, designed to improve minimally invasive therapy of diseases such as coronary artery disease, stroke and cancer.

The new X-ray tube in both the Artis Q and Artis Q.zen series is intended to help physicians identify small vessels up to 70 percent better than conventional X-ray tube technology. The Artis Q.zen combines this innovative X-ray source with a new detector technology designed to support interventional imaging in ultra-low-dose ranges to patients, doctors and medical staff, particularly during longer interventions.

The second generation of Siemens’ flat emitter technology is key to the advances made in the X-ray tube for the Artis Q and Artis Q.zen product lines. Instead of the coiled filaments used in conventional X-ray tubes, flat emitter technology is used exclusively in the new tube to emit electrons. Flat emitters are designed to enable smaller quadratic focal spots that lead to improved visibility of small vessels by up to 70 percent. Both physicians and patients benefit from a high level of detail in imaging-supported interventional therapy. Neurologists can more precisely measure blood circulation in specific areas of the brain, for example, while stenoses in the heart’s smallest blood vessels can be spotted in coronary angiography.

Examinations using ultra-low-dose radiation
The Artis Q.zen series has been designed to combine the X-ray tube with a detector technology that allows detection at ultra-low radiation levels. Artis Q.zen imaging can use doses as low as half the standard levels applied in angiography. This improvement is the result of several innovations, including a fundamental change in detector technology. Until now, almost all detectors have been based on amorphous silicon. The new crystalline silicon structure of the Artis Q.zen detector is designed to be more homogenous, allowing for more effective amplification of the signal, greatly reducing the electronic noise even at ultra-low doses.

The Artis Q.zen was developed to support better imaging quality at ultra-low-dose ranges, reducing the radiation exposure of patients, physicians and medical staff. This is especially important in dose-sensitive application fields such as pediatric cardiology and radiology, or electrophysiology, which is being used more frequently as rates of cardiac arrhythmia increase in an aging population.

Innovative applications for interventional imaging
In addition to the hardware, several software applications have been designed to improve interventional imaging. In coronary artery disease treatment, the applications allow precise correlation of angiography images with ultrasound images taken by a probe inside the coronary arteries. Stents are imaged in real time during therapy, with motion stabilization created by simultaneous correction for the heartbeat.

Other new 3-D applications are designed to image the smallest structures inside the head. Their high spatial resolution is crucial for imaging intracranial stents or other miniscule structures such as the cochlea in the inner ear. Moving organs such as the lungs can be imaged in 3-D in less than three seconds, reducing motion artifacts and the required amount of contrast agent. Through visualization and measurement of blood volumes in the liver or other organs, Siemens’ functional 3-D imaging provides a basis for planning therapies such as chemo-embolization of hepatic tumors.

The Artis Q and Artis Q.zen are pending U.S. Food and Drug Administration (FDA) 510(k) clearance and are not yet commercially available in the United States.

For more information: www.siemens.com/healthcare

Related Content

HeartFlow Announces New Commercial Coverage With UnitedHealthcare
News | Computed Tomography (CT) | July 03, 2018
HeartFlow Inc. announced that UnitedHealthcare now covers the HeartFlow FFRct Analysis, extending access to their 45...
Post-Mortem CT Angiography Illuminates Causes of Death
News | CT Angiography (CTA) | June 25, 2018
Computed tomography (CT) angiography is a useful adjunct to autopsy that is likely to increase the quality of post-...
High Prevalence of Atherosclerosis Found in Lower Risk Patients
News | Magnetic Resonance Imaging (MRI) | June 08, 2018
Whole-body magnetic resonance angiography (MRA) found a surprisingly high prevalence of atherosclerosis in people...
FAST Study Demonstrates High Diagnostic Accuracy of CAAS vFFR
Technology | Angiography | May 22, 2018
Pie Medical Imaging announced that clinical data on its CAAS vFFR (Cardiovascular Angiographic Analysis Systems for...
360 Photos | Angiography | May 03, 2018
A 360 degree view of the newest cath lab at...
Guideline updates and clinical research highlight the need for improved understanding of gender differences by clinicians and patients
Feature | Women's Health | May 03, 2018 | By Jeff Zagoudis
Clinical research has revealed men and women often have different presentations for cardiovascular disease (CVD).
GE's OEC Elite CFD

GE's OEC Elite CFD

Feature | Mobile C-Arms | April 18, 2018 | Jeff Zagoudis
The market for mobile C-arm techn...
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Radiology Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Videos | RSNA 2017 | December 20, 2017
ITN and DAIC Editor Dave Fornell takes a tour of some of the most interesting new medical imaging technologies on the
Philips Azurion Platform Improves Clinical Workflow and Staff Experience Benefits
News | Angiography | December 04, 2017
Philips recently announced the results of a comprehensive, independent, two-year study demonstrating the clinical...
Overlay Init